Evidence map›Paper›PMID 28725630›Full record

ReviewJournal of traditional and complementary medicine2017

Curcumin: An age-old anti-inflammatory and anti-neoplastic agent.

Matthew C Fadus, Cecilia Lau, Jai Bikhchandani, Henry T Lynch

Abstract readReview
In one paragraph

Review in Journal of traditional and complementary medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed.

  1. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Trial
  2. Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Curcumin Mitigates Streptozotocin-Induced GenotoxicityCombinatorial chemistry & high throughput screening · 2025
    Article
  9. Article
  10. Review
  11. A full-spectrumFrontiers in pharmacology · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew C FadusChildren's Hospital of Philadelphia, Philadelphia, PA 19104, United States.
Cecilia LauDuke University, Department of Psychiatry, Durham, NC, United States.
Jai BikhchandaniCreighton University, Department of Preventive Medicine, Omaha, NE 68178, United States.
Henry T LynchCreighton University, Department of Preventive Medicine, Omaha, NE 68178, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin is a natural anti-inflammatory agent that has been used for treating medical conditions for many years. Several experimental and pharmacologic trials have demonstrated its efficacy in the role as an anti-inflammatory agent. Curcumin has been shown to be effective in treating chronic conditions like rheumatoid arthritis, inflammatory bowel disease, Alzheimer's and common malignancies like colon, stomach, lung, breast, and skin cancers. As treatments in medicine become more and more complex, the answer may be something simpler. This is a review article written with the objective to systematically analyze the wealth of information regarding the medical use of curcumin, the "curry spice", and to understand the existent gaps which have prevented its widespread application in the medical community.

Indexed as

Anti-inflammatoryCancerChemoprophylaxisCurcuminCurryTurmeric

Identifiers

PMID28725630
PMCPMC5506636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.